Drug Profile
Research programme: biodefence vaccines - AlphaVax
Alternative Names: Biodefense vaccines - AlphaVax; Botulinum toxin vaccine - AlphaVax; Ebola virus vaccine - AlphaVax; Equine encephalomyelitis virus vaccine - AlphaVax; Filovirus vaccine - AlphaVax; Marburg virus vaccine - AlphaVax; Smallpox virus vaccine - AlphaVax; VEE/EEE/WEE vaccine - Alpha Vax; Venezuelan/Eastern/Western Equine Encephalitis virus vaccine - AlphaVaxLatest Information Update: 28 Jul 2022
Price :
$50
*
At a glance
- Originator AlphaVax
- Class Bacterial vaccines; Synthetic vaccines; Vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Botulism; Eastern equine encephalomyelitis; Marburg virus disease; Smallpox; Venezuelan equine encephalomyelitis; Western equine encephalitis virus infections
Most Recent Events
- 28 Jul 2022 No recent reports of development identified for preclinical development in Botulism(Prevention) in USA
- 28 Jul 2022 No recent reports of development identified for preclinical development in Eastern-equine-encephalomyelitis(Prevention) in USA
- 28 Jul 2022 No recent reports of development identified for preclinical development in Marburg virus disease(Prevention) in USA